Beyond effector caspase inhibition: Bcl2L12 neutralizes p53 signaling in glioblastoma.
about
The role of Bcl-2 family proteins in therapy responses of malignant astrocytic gliomas: Bcl2L12 and beyondRole of apoptosis in diseaseSpherical nucleic acid nanoparticle conjugates as an RNAi-based therapy for glioblastomaConditioned media from human adipose tissue-derived mesenchymal stem cells and umbilical cord-derived mesenchymal stem cells efficiently induced the apoptosis and differentiation in human glioma cell lines in vitromiR-182 integrates apoptosis, growth, and differentiation programs in glioblastoma.The novel member of the BCL2 gene family, BCL2L12, is substantially elevated in chronic lymphocytic leukemia patients, supporting its value as a significant biomarker.Targeting the p53 signaling pathway in cancer therapy - the promises, challenges and perils.Long Noncoding RNA LOC100129973 Suppresses Apoptosis by Targeting miR-4707-5p and miR-4767 in Vascular Endothelial Cells.Wild-type and mutant p53 mediate cisplatin resistance through interaction and inhibition of active caspase-9Recent discoveries in the cycling, growing and aging of the p53 fieldRecent progress in genetics of aging, senescence and longevity: focusing on cancer-related genes.Inhibition of U-87 MG glioblastoma by AN-152 (AEZS-108), a targeted cytotoxic analog of luteinizing hormone-releasing hormone.Loss of PDCD4 contributes to enhanced chemoresistance in Glioblastoma multiforme through de-repression of Bcl-xL translation.Estrogen receptor β isoform 5 confers sensitivity of breast cancer cell lines to chemotherapeutic agent-induced apoptosis through interaction with Bcl2L12.Potentiation of cytotoxic chemotherapy by growth hormone-releasing hormone agonistsCurrent understanding of the role and targeting of tumor suppressor p53 in glioblastoma multiforme.Tumor necrosis factor suppresses interleukin 10 in peripheral B cells via upregulating Bcl2-like protein 12 in patients with inflammatory bowel disease.C-terminally truncated form of αB-crystallin is associated with IDH1 R132H mutation in anaplastic astrocytoma.Ubiquitin-specific protease 2a stabilizes MDM4 and facilitates the p53-mediated intrinsic apoptotic pathway in glioblastoma.HDAC inhibitor DWP0016 activates p53 transcription and acetylation to inhibit cell growth in U251 glioblastoma cells.Radioresistance of human glioma spheroids and expression of HSP70, p53 and EGFr.Spherical nucleic acids for precision medicine.Apoptosis triggered by isoquercitrin in bladder cancer cells by activating the AMPK-activated protein kinase pathway.Searching new signals for production traits through gene-based association analysis in three Italian cattle breeds.Hyperhomocysteinemia induces cardiac injury by up-regulation of p53-dependent Noxa and Bax expression through the p53 DNA methylation in ApoE(-/-) mice.Post-shock mesenteric lymph drainage ameliorates cellular immune function in rats following hemorrhagic shock.GSK3β‑mediated Ser156 phosphorylation modulates a BH3‑like domain in BCL2L12 during TMZ‑induced apoptosis and autophagy in glioma cells.
P2860
Q26851645-69FD30B4-9021-42D6-822D-A0C60BCC2F39Q26865637-42987E2C-D0BC-4604-B52C-0591AAA05645Q30577878-A48A27E8-D9B9-4B14-8B9C-95F5AE14A2B2Q33757933-2FC9CBC9-9825-47E8-884D-BDB336B12F2FQ35293772-3FCBD032-56B6-483C-8C95-2B1E9957494CQ35584788-BCD446BA-0B6B-43C6-BBF1-E77BB46A727BQ35795073-5B68C872-28BB-45A9-BBC9-F3905B926BD7Q36591548-D229F44C-0323-458D-BD16-6FE99B6AB859Q36618628-123D7015-2861-4C2D-9FF0-3F8941E59660Q36736358-76C23773-60AD-4F01-828E-7373AFC8C54CQ36926098-533A2284-9F0F-4F95-B7A4-F966DEAD7C67Q37029375-195C9F56-CCA7-43BA-8D4A-77BDD9A9E4A2Q37299266-3BD3A742-2474-42D4-BDD1-4E6443F38172Q37382513-8569147C-3198-47A2-87D7-75ED8A3BA813Q37495105-8EEA518E-6A2E-42CB-9A73-C2F9C9F1C9A7Q38112074-EEA19440-FB77-44E2-95A1-C13727622D3EQ39000759-87FC58D1-5ACD-4CD6-9E8F-74B1862D23D3Q39029492-447E302B-D887-4BE3-966A-8000FAF2FB60Q39032658-976BD405-12EB-416C-8A2E-3B2AEE8CEF3DQ39214706-AD3FCD1A-FF22-41B3-A386-9BB42B26F32AQ39352683-02E4F893-75C6-4EB3-AA09-399978E51CF5Q42405739-9D80AC6B-B098-4E7C-92B7-5E32656E538DQ47632706-44AB43F0-A26F-4C91-8AF5-9C3282C0DA78Q50974272-069EDEED-74F7-4499-88B7-AC169E2B3ECBQ51040011-812D4E2C-929E-4155-9745-4B8808DFBE45Q53037532-C10B1871-92E9-4CDC-B59D-8D4B1BA98D93Q54110692-4333ED47-CB2E-4C1B-84A7-5EEBB66ECC5E
P2860
Beyond effector caspase inhibition: Bcl2L12 neutralizes p53 signaling in glioblastoma.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Beyond effector caspase inhibition: Bcl2L12 neutralizes p53 signaling in glioblastoma.
@ast
Beyond effector caspase inhibition: Bcl2L12 neutralizes p53 signaling in glioblastoma.
@en
Beyond effector caspase inhibition: Bcl2L12 neutralizes p53 signaling in glioblastoma.
@nl
type
label
Beyond effector caspase inhibition: Bcl2L12 neutralizes p53 signaling in glioblastoma.
@ast
Beyond effector caspase inhibition: Bcl2L12 neutralizes p53 signaling in glioblastoma.
@en
Beyond effector caspase inhibition: Bcl2L12 neutralizes p53 signaling in glioblastoma.
@nl
prefLabel
Beyond effector caspase inhibition: Bcl2L12 neutralizes p53 signaling in glioblastoma.
@ast
Beyond effector caspase inhibition: Bcl2L12 neutralizes p53 signaling in glioblastoma.
@en
Beyond effector caspase inhibition: Bcl2L12 neutralizes p53 signaling in glioblastoma.
@nl
P2860
P356
P1433
P1476
Beyond effector caspase inhibition: Bcl2L12 neutralizes p53 signaling in glioblastoma.
@en
P2093
Alexander H Stegh
Ronald A DePinho
P2860
P356
10.4161/CC.10.1.14365
P577
2011-01-01T00:00:00Z